Subetta

DRUG3 trials

Sponsors

Materia Medica Holding

Conditions

Impaired Glucose ToleranceType I Diabetes MellitusType II Diabetes Mellitus

Phase 3

Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance

CompletedNCT03725033

Materia Medica HoldingImpaired Glucose Tolerance

Start: 2018-10-10End: 2020-03-23Updated: 2021-02-04

Phase 4

Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus

CompletedNCT01868594

Materia Medica HoldingType I Diabetes Mellitus

Start: 2013-05-07End: 2016-07-10Updated: 2019-05-30

Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus

CompletedNCT01868646

Materia Medica HoldingType II Diabetes Mellitus

Start: 2013-05-07End: 2016-06-15Updated: 2019-05-31

Related Papers

Efficacy and safety of Subetta add-on therapy in type 1 diabetes mellitus: The results of a multicenter, double-blind, placebo-controlled, randomized clinical trial

Diabetes Research and Clinical Practice2018-05-2621 citations